Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neill

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
American Journal of Medical Genetics. Part A|March 11, 2015
Clinical features associated with copy number variations of the 14q32 imprinted gene clusterJill A Rosenfeld, Joyce E Fox, Maria Descartes, et al.
Cancer Research|May 18, 2017
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerHengyu Lu, Nicole Villafane, Turgut Dogruluk, et al.
Molecular Cytogenetics|November 18, 2011
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysisKathryn A Kolquist, Roger A Schultz, Marilyn L Slovak, et al.
Pediatrics|October 17, 2012
Clinical utility of chromosomal microarray analysisJay W Ellison, J Britt Ravnan, Jill A Rosenfeld, et al.
Human Mutation|July 24, 2013
Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delaysAndrey Shuvarikov, Ian M Campbell, Piotr Dittwald, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Cancer Discovery|August 28, 2024
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast CancerJitendra K Meena, Jarey H Wang, Nicholas J Neill, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
Human Mutation|February 1, 2012
Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic featuresAllen N Lamb, Jill A Rosenfeld, Nicholas J Neill, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
American Journal of Medical Genetics. Part A|March 11, 2015
Clinical features associated with copy number variations of the 14q32 imprinted gene clusterJill A Rosenfeld, Joyce E Fox, Maria Descartes, et al.
Cancer Research|May 18, 2017
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerHengyu Lu, Nicole Villafane, Turgut Dogruluk, et al.
Molecular Cytogenetics|November 18, 2011
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysisKathryn A Kolquist, Roger A Schultz, Marilyn L Slovak, et al.
Pediatrics|October 17, 2012
Clinical utility of chromosomal microarray analysisJay W Ellison, J Britt Ravnan, Jill A Rosenfeld, et al.
Human Mutation|July 24, 2013
Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delaysAndrey Shuvarikov, Ian M Campbell, Piotr Dittwald, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Cancer Discovery|August 28, 2024
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast CancerJitendra K Meena, Jarey H Wang, Nicholas J Neill, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
Human Mutation|February 1, 2012
Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic featuresAllen N Lamb, Jill A Rosenfeld, Nicholas J Neill, et al.
Pageof 17